证券代码：300119 证券简称：瑞普生物 公告编号：2025-079 瑞普生物股份有限公司 关于持股 5%以上股东梁武持股在一致行动人之间内部转让 计划完成的公告 股东梁武、图灵私募基金管理（海南）有限公司-图灵麦田6号私募证券投资基金保证 向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 瑞普生物股份有限公司（以下简称"公司"）于 2025 年 7 月 11 日在深圳证 券交易所网站（http://www.szse.cn）及巨潮资讯网（http://www.cninfo.com.cn）披 露了《关于持股 5%以上股东梁武持股拟在一致行动人之间内部转让的公告》（公 告编号：2025-052）。公司持股 5%以上股东梁武先生计划自该内部转让计划公 告披露之日起三个月内以大宗交易方式向其一致行动人转让本公司股份 90.00 万 股，占本公司总股本比例 0.19%。 近日，公司收到梁武先生出具的《关于持股在一致行动人之间内部转让计划 完成的告知函》，梁武先生本次内部转让计划已实施完毕。现将本次股份内部转 让计划实施情况 ...

Core Insights - The report indicates a downward trend in pig prices due to increased supply and policy guidance, leading to accelerated capacity reduction in the industry [1][7][18] - The overall agricultural sector has shown a positive performance with a 1.18% increase week-on-week, while the pig farming segment is experiencing significant losses [11][36] Pig Farming Data Tracking - The number of breeding sows has slightly decreased, with a 0.33% month-on-month decline in September [19] - Pig prices have dropped significantly, with the average price on October 9 being 11.89 CNY/kg, reflecting a week-on-week decrease of 6.16% [28][29] - The profitability of pig farming remains negative, with losses of 152.15 CNY per head for self-bred pigs and 301.04 CNY per head for purchased piglets as of October 10 [36] Poultry Farming Data Tracking - The poultry sector is facing challenges due to outbreaks of avian influenza, but there are investment opportunities in the white-feathered chicken market [37] - The average price for white-feathered meat chickens was 6.88 CNY/kg on October 10, with a slight week-on-week decrease of 0.15% [40] Animal Health Data Tracking - The demand for animal health products is expected to rebound, driven by an increase in livestock numbers and new product launches [47] - Significant growth in vaccine approvals has been noted, with various companies making advancements in vaccine development [47] Seed Industry Data Tracking - The prices of key agricultural commodities such as wheat and soybean meal have increased, indicating a positive trend in the seed industry [50] - The report emphasizes the importance of strengthening food security and promoting the commercialization of biological breeding [50] Pet Industry Data Tracking - Pet food exports have decreased by 15.5% year-on-year, amounting to 834 million CNY in August 2025 [56] - Domestic sales of pet food are growing rapidly, with a combined growth rate of 3% across major e-commerce platforms in September [57]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [6] Core Insights - The company is positioned as a leader in the veterinary medicine sector, with a strong focus on expanding its pet vaccine and medical services segments, which are expected to drive future growth [3][4][5][6] - The company reported a net profit of 116 million yuan in Q1 2025, reflecting a year-on-year increase of 32.45% [3] - The pet vaccine segment, particularly the "Rui Miao Shu" cat trivalent vaccine, is a pioneer in domestic production, with significant revenue growth anticipated [4][17] - The company is actively pursuing international expansion, enhancing its product registration and compliance with overseas GMP standards [3][6] Summary by Sections 1. Company Overview - The company, established in 1998, is a high-tech enterprise focused on animal health, with a comprehensive portfolio including veterinary biological products, pharmaceuticals, and functional additives [19][20] - It operates over 20 subsidiaries and has more than 500 product registrations, making it one of the largest veterinary medicine companies in China [19][21] 2. Financial Analysis - The company achieved a revenue of 3.07 billion yuan in 2024, a 36.5% increase year-on-year, while the net profit was 301 million yuan, reflecting a decline of 33.61% due to increased costs associated with business expansion [37][38] - The pet segment's revenue reached 690 million yuan in 2024, accounting for 22% of total revenue, indicating rapid growth in this area [37][38] 3. Pet Vaccine and Medical Services - The pet vaccine market is projected to grow significantly, with the current market size estimated at 40 billion yuan, indicating substantial room for domestic products to replace imports [4][17] - The company has established a robust ecosystem in the pet healthcare sector, collaborating with nearly 600 pet hospitals and 3,400 pet stores through its supply chain [5][18] 4. Revenue Projections - Revenue forecasts for 2025-2027 are 36.17 billion, 42.58 billion, and 50.00 billion yuan, respectively, with corresponding EPS estimates of 0.87, 1.08, and 1.33 yuan [6][11]

Group 1 - As of October 10, the Tianjin Free Trade Zone concept rose by 2.13%, ranking third among concept sectors, with 12 stocks increasing in value [1] - Notable gainers include Jintou City Opening, which hit the daily limit, and HNA Technology, Ruipu Biology, and Haitai Development, which rose by 8.83%, 3.16%, and 2.42% respectively [1] - The leading decliners were Tianjin Pulin, Hengyin Technology, and Jiuan Medical, which fell by 0.49%, 0.20%, and 0.13% respectively [1] Group 2 - The Tianjin Free Trade Zone concept saw a net inflow of 67 million yuan, with seven stocks receiving main capital inflows [2] - HNA Technology led the net inflow with 61.57 million yuan, followed by Jintou City Opening, Tianjin Port, and Haitai Development with net inflows of 61.16 million yuan, 9.59 million yuan, and 4.21 million yuan respectively [2] - The inflow ratios for Jintou City Opening, HNA Technology, and Tianjin Port were 36.56%, 8.67%, and 5.82% respectively [3] Group 3 - The top stocks in the Tianjin Free Trade Zone concept based on net capital flow included HNA Technology, Jintou City Opening, Tianjin Port, and Haitai Development, with respective daily price changes of 8.83%, 10.20%, 1.71%, and 2.42% [3] - The trading volume and turnover rates for these stocks were also highlighted, with Jintou City Opening having a turnover rate of 5.68% and HNA Technology at 5.72% [3]

Core Insights - The animal health sector experienced a rise of 1.98% on October 10, with Bio-Pharmaceuticals leading the gains [1] - The Shanghai Composite Index closed at 3897.03, down 0.94%, while the Shenzhen Component Index closed at 13355.42, down 2.7% [1] Stock Performance - Bio-Pharmaceuticals (600201) closed at 10.16, up 4.42% with a trading volume of 808,300 shares and a transaction value of 815 million [1] - Other notable performers included: - Houbang Holdings (002141) at 3.85, up 3.77% [1] - Ruipu Biological (300119) at 21.87, up 3.16% [1] - Dayu Biological (920970) at 66.6, up 2.62% [1] - Huisheng Biological (300871) at 21.33, up 2.06% [1] Capital Flow - The animal health sector saw a net inflow of 111 million from institutional investors, while retail investors experienced a net outflow of 96.24 million [2] - The capital flow for key stocks included: - Bio-Pharmaceuticals (600201) with a net inflow of 73.87 million from institutional investors [3] - Huisheng Biological (300871) with a net inflow of 17.64 million from institutional investors [3] - Houbang Holdings (002141) with a net inflow of 16.38 million from institutional investors [3]

Group 1 - The pet economy concept stocks in the A-share market are experiencing a counter-trend rise, with notable increases in stock prices for several companies [1] - Yiyi Co., Ltd. reached a 10% limit up, while Babi Food increased by 6%, and other companies like Yuanfei Pet and Jieya Co. saw rises exceeding 5% [1] - The overall trend indicates a positive sentiment in the pet industry, as reflected by the MACD golden cross signal formation [1] Group 2 - Yiyi Co., Ltd. has a total market value of 6.346 billion and a year-to-date increase of 113.23% [2] - Babi Food has a market capitalization of 5.776 billion with a year-to-date increase of 45.81% [2] - Yuanfei Pet has a market value of 4.620 billion and a year-to-date increase of 54.05% [2] - Jieya Co. has a market capitalization of 3.847 billion and a year-to-date increase of 87.03% [2] - Petty Co. has a market value of 4.693 billion with a year-to-date increase of 8.49% [2] - Other companies like Biological Co. and Lusi Co. also showed significant increases in their stock prices and market values [2]

Group 1 - The A-share market's pet economy concept stocks are experiencing a counter-trend rise, indicating strong investor interest in this sector [1] - Yiyi Co., Ltd. has reached a 10% daily limit increase, showcasing significant market confidence [1] - Other notable performers include Babi Foods with a 6% increase, and Yuanfei Pet, Jeya Co., Ltd. with over 5% gains [1] Group 2 - Peti Co., Ltd., Bio Co., Ltd., Lusi Co., Ltd., and Shuangta Foods have all seen increases of over 4%, reflecting a broad positive sentiment in the pet industry [1] - Meino Biological, Haoyue Nursing, Ruipu Biological, and Chuangyuan Co., Ltd. have also reported gains exceeding 3%, further indicating the sector's resilience [1]

Core Points - The Shanghai Composite Index is at 3927.63 points, slightly down by 0.16%, with a total trading volume of 1.2446 trillion yuan [1] - A total of 181 A-shares have surpassed the half-year line, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - Li Min Co., Ltd. (002734) has a deviation rate of 4.31% with a price increase of 6.27% [1] - Yuanda Environmental Protection (600292) shows a deviation rate of 3.35% and a price increase of 3.93% [1] - Oriental Carbon (920175) has a deviation rate of 3.28% with an 8.17% price increase [1] Trading Activity - The total trading volume for A-shares today is reported at 1.2446 trillion yuan [1] - The stocks with the smallest deviation rates include Lian Ke Technology, Lingkang Pharmaceutical, and Publishing Media, which have just crossed the half-year line [1] Deviation Rate Rankings - The top stocks with the highest deviation rates include: - Li Min Co., Ltd. (002734) at 4.31% - Yuanda Environmental Protection (600292) at 3.35% - Oriental Carbon (920175) at 3.28% [1] - Other notable stocks with significant price increases and deviation rates include: - Han Commercial Group (600774) at 3.19% - Rui Pu Biological (300119) at 2.99% [1]

Core Insights - The animal health sector experienced a slight increase of 0.01% on October 9, with the leading stock being Driveline [1] - The Shanghai Composite Index closed at 3933.97, up 1.32%, while the Shenzhen Component Index closed at 13725.56, up 1.47% [1] Stock Performance - Driveline (920275) closed at 9.57, up 1.38%, with a trading volume of 17,600 and a turnover of 11.63 million [1] - Jinhai Biological (002688) closed at 6.77, up 1.20%, with a trading volume of 183,400 and a turnover of 123 million [1] - Biological Shares (600201) closed at 9.73, up 0.93%, with a trading volume of 470,500 [1] - Huisheng Biological (300871) closed at 20.90, up 0.87%, with a trading volume of 41,600 [1] - Other notable stocks include Plai Ke (603566) at 13.82, up 0.58%, and Haili Biological (603718) at 6.81, up 0.15% [1] Capital Flow - The animal health sector saw a net outflow of 53.09 million from institutional investors, while retail investors had a net inflow of 28.12 million [2] - The total net inflow from speculative funds was 24.97 million [2] Individual Stock Capital Flow - Ruipu Biological (300119) had a net inflow of 7.31 million from institutional investors, while it experienced a net outflow of 9.14 million from retail investors [3] - Plai Ke (603566) saw a net inflow of 2.41 million from institutional investors but a net outflow of 6.28 million from retail investors [3] - Other stocks like *ST Green Kang (002868) and Jinhai Biological (002688) experienced significant net outflows from institutional investors [3]

Core Viewpoint - The animal health sector experienced a rise of 0.98% on September 30, with *ST Lvkang leading the gains, while the overall market indices also showed positive movement [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3882.78, up 0.52% [1]. - The Shenzhen Component Index closed at 13526.51, up 0.35% [1]. - The animal health sector's individual stock performance is detailed in a table, highlighting various stocks' closing prices and percentage changes [1]. Group 2: Stock Performance - *ST Lvkang (002868) closed at 28.01, with a gain of 3.51% and a trading volume of 16,700 shares, amounting to approximately 46.61 million yuan [1]. - Other notable stocks include: - Biological Shares (600201) at 9.64, up 1.69% with a trading volume of 412,400 shares [1]. - Jinhe Biological (002688) at 6.69, up 1.67% with a trading volume of 150,600 shares [1]. - KQ Bio (688526) at 17.72, up 1.37% with a trading volume of 32,700 shares [1]. Group 3: Capital Flow - The animal health sector saw a net inflow of 3.40 million yuan from institutional investors, while retail investors experienced a net outflow of 28.01 million yuan [2][3]. - The detailed capital flow for individual stocks indicates varying levels of net inflow and outflow among different companies [3]. - For instance, Biological Shares (600201) had a net inflow of approximately 19.60 million yuan from institutional investors, while *ST Lvkang (002868) faced a net outflow of about 6.49 million yuan [3].